In Women with Previous Pregnancy Hypertension, Levels of Cardiovascular Risk Biomarkers May Be Modulated by Haptoglobin Polymorphism

Table 4

Comparison of cardiovascular risk biomarkers in women with normal blood pressure in pregnancy (NBPP) and women with preeclampsia (PE).

	NBPP; 𝑛 (mean ± SD)	PE; 𝑛 (mean ± SD)	𝑃 value
CRP (mg/L)^††	56 (0.40±0.11)	83 (0.60±0.07)	0.179
MPO (ng/mL)^†	24 (62.27±30.88)	32 (85.67±39.39)	0.020
Nitrites (𝜇mol/L)^†	25 (10.12±3.80)	32 (19.12±7.01)	<0.001
NO𝑥 (𝜇mol/L)^†	25 (79.18±38.06)	29 (99.44±39.52)	0.061
AST (UI/L)^††	60 (18.00±0.65)	90 (19.00±0.72)	0.083
ALT (UI/L)^††	60 (15.50±1.03)	90 (19.00±1.36)	0.003
t-Cholesterol (mg/dL)^†	60 (206.57±34.29)	90 (207.18±39.33)	0.922
Non HDL cholesterol^†	59 (157.00±35.60)	90 (158.17±37.96)	0.851
LDL (mg/dL)^†	59 (138.75±32.30)	90 (158.17±37.96)	0.855
HDL (mg/dL)^††	59 (50.00±1.11)	90 (49.00±0.89)	0.479
Apo A (mg/dL)^†	58 (0.95±0.20)	87 (0.99±0.17)	0.129
Apo B (mg/dL)^†	58 (0.59±0.13)	87 (0.64±0.14)	0.023

†Independent sample 𝑡-test; and values are means ± standard deviation (SD).
††Mann-Whitney 𝑈 test; and values are median ± standard error (SE).
C-reactive protein (CRP), Myeloperoxidase (MPO), nitrites, nitric oxide metabolites (NO_𝑥), aspartate transaminase (AST), alanine transaminase (ALT), total cholesterol (t-cholesterol), non HDL cholesterol, apolipoprotein A and B (Apo B and Apo A), low density lipoprotein (LDL), and high density lipoprotein (HDL).